期刊
FUTURE MEDICINAL CHEMISTRY
卷 2, 期 12, 页码 1813-1822出版社
FUTURE SCI LTD
DOI: 10.4155/FMC.10.259
关键词
-
资金
- Wellcome Trust [DBB2800]
- Age UK [DBB2200]
- Alzheimers Research UK [ART-PPG2008B-2] Funding Source: researchfish
- Cancer Research UK [11738] Funding Source: researchfish
The concept of peptides as therapeutic agents has been historically disregarded by the pharmaceutical industry on account of their susceptibility to degradation, their size and consequent limitations in methods of delivery. Recently, however, there has been a surge of interest in peptides and their mimetics as potential antagonists for therapeutic intervention. This is in part due to the increased half-life and oral availability that has been achieved for a number of peptide-based systems, the introduction and acceptance of alternative delivery methods, and the prevalence of proteomics to identify countless protein-protein interaction targets. The use of peptides and molecules that mimic their function therefore has great potential to effectively target a range of proteins that are pathogenically implicated in numerous diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据